It’s hard to discuss about CF, when there’s really none. They’re not out of the weed work in terms of dominance and there’s a lot of CAPEX associated. Especially with the number of initiatives they are rolling out that requires huge capital and stock issuance.
If we stop the growth and tried to extract cash from the business, it would be $50-200M tops?
